Reed E et al. Extracellular Matrix Profiling and Disease Modelling in Engineered Vascular Smooth Muscle Cell Tissues. Matrix Biology Plus. 2022 16, 100122.
Gutmann C et al. SGLT2 inhibitors in heart failure: insights from plasma proteomics. European Heart Journal. 2022
Schulte C & Singh B et al. Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes. J Mol Cell Cardiol Plus. 2022 1, 100014.
Räber L et al.Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial. JAMA. 2022 327(18), 1771-1781.
Gutmann C & Mayr M. Circulating microRNAs as biomarkers and mediators of platelet activation. Platelets. 2022 33(4), 512-519.

Yin X et al.Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic Apheresis. Hormone and Metabolic Research. 2022 54(04), 238-249.
Dave J et al. Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modelling a European cardiomyopathy with global impact. Cardiovascular Research. 2022
Bechmann N et al.Sexual dimorphism in COVID-19: potential clinical and public health implications. The Lancet Diabetes & Endocrinology. 2022
van der Velden J et al. Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart. Cardiovascular Research. 2022
Takov K et al.Isolation of Circulating Extracellular Vesicles by High-Performance Size-Exclusion Chromatography. Extracellular Vesicles in Diagnosis and Therapy. 2022, 31-40 Humana, New York